Dov Charles Goldenberg

Dov Charles Goldenberg

Auto-generated profile, based on publicly available information

Dov Charles Goldenberg

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2025 in Journal of Vascular Anomalies
Verified
Journal Article
Open access
DGDov Charles Goldenberg
Dov Charles Goldenberg
MVMiikka Vikkula
Miikka Vikkula
APAnthony Penington
Anthony Penington
FBFrancine Blei
Francine Blei
LSLeo Schultze-Kool
Leo Schultze-Kool
IFIlona J. Frieden
Ilona J. Frieden
Introduction: The International Society for the Study of Vascular Anomalies developed in 1996 a classification of vascular anomalies that became internationally accepted. The main feature was the division of vascular anomalies into 2 categories: vascular tumors and malformations. Major revisions occurred in 2014 and 2018, for updates and inclusion of newly described lesions. Major advances occurred in recent years, with improved understanding of genetic basis of vascular anomalies and its relevance in therapeutics. It created a demand for a new revision of the International Society for the Study of Vascular Anomalies (ISSVA) classification, and the process is presented in this study. Methods: A group was created in 2019, joining experts from different specialties and coordinated by the ISSVA Scientific Committee, to reevaluate the 2018 Classification on each subtype of vascular anomaly, considering the clinical presentation, histological subtypes, flow velocity, and genetic aspects. After several multidisciplinary online discussions and in-person meetings at ISSVA Congresses (2022, 2023, and 2024) the proposal for the new classification was presented for ISSVA members ratification, after an opening window for comments and suggestions. A new tool was created, named “Glossary of Vascular Anomalies,” along the contours of a medical dictionary. Results: A new layout of the classification was designed. The visualization begins with a general “Landing Page” where the basic division into vascular tumors and malformations is specified. For vascular tumors, the subdivision was kept between benign, borderline, and malignant tumors. For vascular malformations, the divisions were presented as fast-flow lesions, slow-flow lesions, and developmental anomalies of named vessels. A full classification table page with all updated modifications followed the landing page. All changes and new terms are described in detail and summarized in a table. The glossary lists and explains, in alphabetic order, all technical terms, abbreviations, acronyms, eponyms, genes, and syndromes related to vascular anomalies. Conclusions: The presented updated ISSVA classification of vascular anomalies reflects our evolving understanding of vascular anomalies, which will be continuously updated by a dedicated committee of ISSVA.

1 February 1997 in Shock
Verified
Journal Article
Closed access
RYRiad N. Younes
Riad N. Younes
FAFrederico Aun
Frederico Aun
CCChan T. Ching
Chan T. Ching
DGDov C. Goldenberg
Dov C. Goldenberg
MFMárcia H. Franco
Márcia H. Franco
DBDario Birolini
Dario Birolini
Hypertonic solutions effectively improve hemodynamic parameters in patients admitted to the emergency room. However, no significant differences in outcome were observed compared with standard isotonic treatment in most previously published studies. This study evaluates pretreatment prognostic factors that predict a beneficial effect of hypertonic solution in patients admitted to the emergency room with hemorrhagic hypovolemia in a prospective double-blind fashion. The patients (n = 212) were randomized upon admission to receive 250 mL intravenous (i.v.) bolus of hypertonic 7.5% NaCl + 6% dextran (HSD, n = 101), or isotonic 0.9% NaCl solutions (IS, n = 111) as the first treatment, followed by standard resuscitation. Pretreatment factors assessed were sex, age, cause of hypovolemia, revised trauma score (RTS), Glasgow index, and mean arterial pressure (MAP) on admission. Both groups were compared for survival at 24 h and 30 days postadmission. Infused volumes were registered. HSD administration significantly increased MAP and reduced i.v. crystalloid infusions to maintain hemodynamic parameters, compared with IS. There was no difference between groups in the number of blood transfusions administered. Overall complication rates in both groups were similar (24%). There was a significant difference (p < .03) in overall (30 days) survival rate between HSD (73%) and IS (64%) groups. The 24 h survival rate was significantly lower in IS (72%) compared with HSD (87%); p < .01. Multivariate analyses showed that RTS and MAP were identified as independent predictors for 24 h survival in the group that received HSD. When evaluated for overall survival rate, hypertonic infusion benefited significantly only patients with MAP < 70 mmHg (p < .01).

1 February 2015 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
DGDov C. M.D. Goldenberg
Dov C. M.D. Goldenberg
PHPatricia Y. Hiraki
Patricia Y. Hiraki
JCJose Guilherme M.D. Caldas
Jose Guilherme M.D. Caldas
PPPaulo Puglia
Paulo Puglia
TMTatiana M. M.D. Marques
Tatiana M. M.D. Marques
RGRolf M.D. Gemperli
Rolf M.D. Gemperli
Background: Surgical resection after embolization is the most accepted approach to treating arteriovenous malformations. The authors analyzed the outcome of surgically treated patients and how surgical resection was influenced by multiple embolizations. Methods: Thirty-one patients were included from January of 2000 to December of 2012. The mean patient age was 24.9 years. Anatomical involvement, definition of limits, functional impairment, number of embolizations, type of resection, reconstruction method, blood transfusion, and hospital stay were evaluated. Morbidity, mortality, and regrowth rates and need for additional procedures were evaluated. Results: Lesions were preferentially located at the orbits, cheeks, and lips. The number of embolizations per patient increased with lesion complexity. In 22 cases, total excision was accomplished, and in nine, subtotal resections were performed to favor function. After multiple embolizations, better lesion identification was observed. Primary closure was performed in 20 cases, local flaps were performed in seven cases, axial flaps were performed in two patients, and free flaps were performed in two cases. There were no deaths. Regrowth rates were influenced by limits between arteriovenous malformations and surrounding tissues (15.8 percent of cases with precise limits versus 58.3 percent of lesions with imprecise limits; p = 0.021) and by type of resection (18.2 percent of cases after total resection versus 66.7 percent after subtotal resections; p = 0.015). Conclusions: Multiple therapeutic embolizations seem to increase safety in the treatment of arteriovenous vascular malformations and suggest an additional positive effect besides bleeding control. Preoperative definition of limits and establishment of conditions for total resection are critical to determine management and risk of regrowth. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

1 March 2007 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
DGDov Charles Goldenberg
Dov Charles Goldenberg
NANivaldo Alonso
Nivaldo Alonso
FGFernanda C. Goldenberg
Fernanda C. Goldenberg
EGEloisa S. Gebrin
Eloisa S. Gebrin
TATeresinha S. Amaral
Teresinha S. Amaral
MFMarcus C. Ferreira
Marcus C. Ferreira
Surgically assisted rapid palatal expansion (SARPE) is the procedure of choice for treating transverse maxillary deficiency in adult patients. The use of computed tomography (CT) as a method of evaluating the efficiency of this procedure has not been yet reported. Consequently, few landmarks for use in evaluating maxillary expansion have been defined. The goals of the present study were to define parameters to assess skeletal changes after SARPE and to use CT to evaluate those parameters. From June of 2004 to May of 2005, 15 patients underwent SARPE (a modified Le Fort I maxillary osteotomy without pterygomaxillary separation, together with a sagittal palatal osteotomy) according to a defined protocol. To determine the pattern of transversal expansion, linear and angular measurements of the anterior, intermediate, and posterior portions of the maxilla were evaluated in axial and coronal views. The cross-sectional area of the maxilla was calculated to obtain general information about maxillary expansion. The reliability of the method was confirmed. Significant overall expansion was observed. However, different patterns of expansion were seen in the three regions analyzed. In the anterior and intermediate portions of the maxilla, the increase in maxillary width was greater than that observed in the posterior portion. The transverse expansion of the maxilla achieved through SARPE without pterygoid plate separation was less than uniform. The accurate evaluation of the postoperative changes was heavily dependent upon images acquired through CT.

1 November 2008 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
NANivaldo Alonso
Nivaldo Alonso
RFRenato da Silva Freitas
Renato da Silva Freitas
GCGilvani Azor de Oliveira e Cruz
Gilvani Azor de Oliveira e Cruz
DGDov Goldenberg
Dov Goldenberg
ATAndre Ricardo Dallʼoglio Tolazzi
Andre Ricardo Dallʼoglio Tolazzi
: Tessier no. 4 facial cleft is a rare, complex, and challenging craniofacial malformation. The present article aims to describe different clinical features evidenced in 21 cases of this malformation, discussing a 20-year experience with and evolution of its surgical treatment. : Some demographic data, clinical features, and reconstructive results were evaluated retrospectively. These patients have been evaluated and treated in three specialized Brazilian craniofacial centers. Nineteen were already operated on, with a mean follow-up of 3.5 years (range, 1 to 20 years). : Sex distribution showed a male prevalence (2:1). The average age of initial treatment was 5.4 years. Four cases were affected on the right side of the face, seven on the left, and 10 bilaterally. Six patients had other rare associated facial clefts, including nos. 5 (three patients), 7, 9, and 10. Cleft upper lip was evidenced in all patients, and maxillary hypoplasia was present in five and maxilla cleft in eight. Lower eyelid coloboma was seen in almost every case (19 patients); 10 of these had medial canthus dystopia. Four patients had amniotic bands in the limbs. Surgical repair was individualized to each patient. Surgical experience gained with these patients allowed the authors to develop some technical modifications, which have improved aesthetic results, camouflaging scars into natural folds and anatomical units, without compromising functional outcomes. : The great majority of Tessier no. 4 facial clefts can be appropriately treated using local flaps. Classic techniques are extremely useful, but long-term results could be improved if the technical modifications described were adopted.

1 December 2008 in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
Verified
Journal Article
Closed access
DGDov C. Goldenberg
Dov C. Goldenberg
FGFernanda C. Goldenberg
Fernanda C. Goldenberg
NANivaldo Alonso
Nivaldo Alonso
EGEloisa S. Gebrin
Eloisa S. Gebrin
TATheresinha S. Amaral
Theresinha S. Amaral
MFMarcus C. Ferreira
Marcus C. Ferreira